Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Rajesh Babu Medapati"'
Autor:
Venkata Ramalingayya Grandhi, Narender Ganuga, Rajesh Babu Medapati, Jayaprakash Tadiparthi, Pradeep Jayarajan, Anil K Shinde, Rajesh Kumar Badange, Ramakrishna Nirogi
Publikováno v:
Alzheimer's & Dementia. 18
Autor:
Ramkumar Subramanian, Vijay Benade, Arunkumar Manoharan, Narender Ganuga, Ramakrishna Nirogi, Rajesh Kumar Badange, Surendra Petlu, Venkat Jasti, Rajesh Babu Medapati, Gopinadh Bhyrapuneni, Shinde Anil Karbhari, Venkata Ramalingayya Grandhi, Renny Abraham, Pradeep Jayarajan, Sudhakar Gandipudi
Publikováno v:
Journal of Psychopharmacology. 35:713-729
Background: Central histamine H3 receptors are a family of presynaptic auto and heteroreceptors. Blockade of the presynaptic H3 receptors activates the downstream pathway(s) involved in the processes of learning and memory, making it a potential ther
Autor:
Ramakrishna, Nirogi, Abdul Rasheed, Mohammed, Anil Karbhari, Shinde, Shankar Reddy, Gagginapally, Durga Malleshwari, Kancharla, Srinivasa Rao, Ravella, Narsimha, Bogaraju, Vanaja Reddy, Middekadi, Ramkumar, Subramanian, Raghava Choudary, Palacharla, Vijay, Benade, Nageswararao, Muddana, Renny, Abraham, Rajesh Babu, Medapati, Jagadeesh Babu, Thentu, Venkat Reddy, Mekala, Surendra, Petlu, Bujji Babu, Lingavarapu, Sivasekhar, Yarra, Narendra, Kagita, Vinod Kumar, Goyal, Santosh Kumar, Pandey, Venkat, Jasti
Publikováno v:
Journal of medicinal chemistry. 64(15)
A series of oxadiazole derivatives were synthesized and evaluated as 5-hydroxytryptamine-4 receptor (5-HT
Autor:
Ramasastry Kambhampati, Ramkumar Subramanian, Renny Abraham, Nageswararao Muddana, Venkat Jasti, Venkat Reddy Mekala, Rajesh Babu Medapati, Ramakrishna Nirogi, Vijay Benade, Gopinadh Bhyrapuneni, Anil Shinde, Pradeep Jayarajan
Publikováno v:
Behavioural Pharmacology. 30:16-35
Research in Alzheimer's disease is going through a big turnaround. New palliative therapies are being reconsidered for the effective management of disease because of setbacks in the development of disease-modifying therapies. Serotonin 6 (5-HT6) rece
Autor:
Ramakrishna Nirogi, Renny Abraham, Pradeep Jayarajan, Venkatesh Goura, Rajesh Kallepalli, Rajesh babu Medapati, Jayaprakash Tadiparthi, Vinod kumar Goyal, Santosh kumar Pandey, Ramkumar Subramanian, Surendra Petlu, Jagadeesh Babu Thentu, Veera Raghava Chowdary Palacharla, Shankar Reddy Gagginapally, Abdul Rasheed Mohammed, Venkat Jasti
Publikováno v:
Psychopharmacology. 239(7)
Ropanicant (SUVN-911) (3-(6-Chloropyridine-3-yloxymethyl)-2-azabicyclo (3.1.0) hexane hydrochloride) is a novel α4β2 nicotinic acetylcholine receptor (nAChR) antagonist being developed for the treatment of depressive disorders.Pharmacological and n
Autor:
Vinod Kumar Goyal, Nageswara Rao Muddana, Veena Reballi, Venkat Reddy Mekala, Jayaprakash Tadiparthi, Maheswari Srirangavaram, Ramakrishna Nirogi, Veera Raghava Chowdary Palacharla, Narender Ganuga, Kumar Bojja, Santosh Kumar Pandey, Rajesh Kumar Badange, Venkata Ramalingayya Grandhi, Pradeep Jayarajan, Rajesh Babu Medapati, Renny Abraham, Gopinadh Bhyrapuneni, Venkatesh Goura
Publikováno v:
Alzheimer's & Dementia. 16
Autor:
Ramakrishna Nirogi, Hemasundar Reddy Talakanti, Narender Ganuga, Renny Abraham, Pradeep Jayarajan, Ramalingayya Grandhi Venkata, Jayaprakash Tadiparthi, Rajesh Babu Medapati
Publikováno v:
Alzheimer's & Dementia. 14
Autor:
Jayaprakash Tadiparthi, Narender Ganuga, Ramakrishna Nirogi, Pradeep Jayarajan, Rajesh Babu Medapati, Joylee Fernandes, Ramalingayya Grandhi Venkata
Publikováno v:
Alzheimer's & Dementia. 13
Autor:
Venugopala Rao Bhatta, Trinath Reedy, Vijay Benade, Gopinadh Bhyrapuneni, Pradeep Jayarajan, Ramakrishna Nirogi, Renny Abraham, Ramasastry Kambhampati, Rajesh Babu Medapati
Publikováno v:
Alzheimer's & Dementia. 13
Autor:
Rajesh Babu Medapati, Sangram Keshari Saraf, Narender Ganuga, Renny Abraham, Hemasundar Reddy Talakanti, Jayaprakash Tadiparthi, Ramakrishna Nirogi, Venkat Jasti, Venkata Ramalingayya Grandhi, Pradeep Jayarajan
Publikováno v:
Alzheimer's & Dementia. 15:P604-P604